Experienced in Infant Hyperglycemia

Dr. Kevan Herold

Endocrinology
Yale-New Haven Hosp-Hme Care Prog
789 Howard Ave, 
New Haven, CT 
Clinical Trials:Currently Recruiting for 2 Trials

Experienced in Infant Hyperglycemia
Yale-New Haven Hosp-Hme Care Prog
789 Howard Ave, 
New Haven, CT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kevan Herold is an Endocrinologist in New Haven, Connecticut. Dr. Herold is rated as an Experienced provider by MediFind in the treatment of Infant Hyperglycemia. His top areas of expertise are Type 1 Diabetes (T1D), Infant Hyperglycemia, Maturity Onset Diabetes of the Young, Islet Cell Transplantation, and Pancreatectomy.

His clinical research consists of co-authoring 193 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in CT
Hospital Affiliations
Yale-New Haven Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Yale-New Haven Hosp-Hme Care Prog
789 Howard Ave, New Haven, CT 06519
Call: 203-785-7474
Other Locations
Radiology And Biomedical Imaging-New Haven-Yale Physicians Building
800 Howard Ave, New Haven, CT 06519
Call: 203-785-2140

Additional Areas of Focus

Dr. Herold has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


11 Clinical Trials

TrialNet Pathway to Prevention of T1D
TrialNet Pathway to Prevention of T1D
Enrollment Status: Recruiting
Publish Date: July 01, 2025
Type 1 Diabetes Extension Study
Type 1 Diabetes Extension Study
Enrollment Status: Recruiting
Publish Date: April 10, 2025
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Administered Subcutaneously to Patients With Type 1 Diabetes Mellitus
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Administered Subcutaneously to Patients With Type 1 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 20, 2025
Intervention Type: Other, Drug
Study Drugs: Pre-Proinsulin, TGF-Beta1, IL-10, IL-2
Study Phase: Phase 1
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes
Enrollment Status: Completed
Publish Date: June 06, 2024
Intervention Type: Drug
Study Drug: CTLA4-Ig (Abatacept)
Study Phase: Phase 2
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Completed
Publish Date: February 01, 2023
Intervention Type: Biological, Drug
Study Drugs: AG019 - Low Dose, Teplizumab, AG019 - High Dose, AG019 - Low or High Dose
Study Phase: Phase 1/Phase 2
A Phase 1 Trial of CD4+CD127lo/-CD25+ Polyclonal Treg Adoptive Immunotherapy With Interleukin-2 for the Treatment of Type 1 Diabetes
A Phase 1 Trial of CD4+CD127lo/-CD25+ Polyclonal Treg Adoptive Immunotherapy With Interleukin-2 for the Treatment of Type 1 Diabetes
Enrollment Status: Completed
Publish Date: October 19, 2021
Intervention Type: Biological
Study Drugs: CD4-Positive/CD127-Low/CD25-Negative Polyclonal Regulatory T Cells, IL-2
Study Phase: Phase 1
Preserving Beta-Cell Function With Tocilizumab in New-onset Type 1 Diabetes (ITN058AI)
Preserving Beta-Cell Function With Tocilizumab in New-onset Type 1 Diabetes (ITN058AI)
Enrollment Status: Completed
Publish Date: September 08, 2021
Intervention Type: Drug, Other
Study Phase: Phase 2
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Biological
Study Phase: Phase 2
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: August 05, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Enrollment Status: Completed
Publish Date: March 19, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

191 Total Publications

Towards insulin independence in type 1 diabetes: Prospects for prevention and cure.
Towards insulin independence in type 1 diabetes: Prospects for prevention and cure.
Journal: PLoS medicine
Published: November 25, 2025
View All 191 Publications
Similar Doctors
Distinguished in Infant Hyperglycemia
Dr. Jonas Leibowitz
Endocrinology
Distinguished in Infant Hyperglycemia
Dr. Jonas Leibowitz
Endocrinology

Endocrinology Diabetes And Osteoporosis Consultants LLP

770 McLean Ave Ste B, 
Yonkers, NY 
 (55.0 miles away)
914-650-2806
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jonas Leibowitz is an Endocrinologist in Yonkers, New York. Dr. Leibowitz is rated as a Distinguished provider by MediFind in the treatment of Infant Hyperglycemia. His top areas of expertise are Hashimoto Thyroiditis, Type 2 Diabetes (T2D), Isolated ACTH Deficiency, and Pituitary Apoplexy.

Advanced in Infant Hyperglycemia
Dr. Beatrice Lupsa
Endocrinology
Advanced in Infant Hyperglycemia
Dr. Beatrice Lupsa
Endocrinology

Yale-New Haven Hosp-Hme Care Prog

789 Howard Ave, 
New Haven, CT 
 (0.1 miles away)
203-785-7474
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Beatrice Lupsa is an Endocrinologist in New Haven, Connecticut. Dr. Lupsa is rated as a Distinguished provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Maturity Onset Diabetes of the Young, and Melorheostosis with Osteopoikilosis.

Advanced in Infant Hyperglycemia
Dr. Silvio Inzucchi
Endocrinology
Advanced in Infant Hyperglycemia
Dr. Silvio Inzucchi
Endocrinology

Yale-New Haven Hosp-Hme Care Prog

789 Howard Ave, 
New Haven, CT 
 (0.1 miles away)
203-785-7474
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Silvio Inzucchi is an Endocrinologist in New Haven, Connecticut. Dr. Inzucchi is rated as an Elite provider by MediFind in the treatment of Infant Hyperglycemia. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, and Pituitary Tumor.

VIEW MORE INFANT HYPERGLYCEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Herold's expertise for a condition
ConditionClose
  • Elite
  • Type 1 Diabetes (T1D)
    Dr. Herold is
    Elite
    . Learn about Type 1 Diabetes (T1D).
    See more Type 1 Diabetes (T1D) experts
      • Experienced
      • Diabetic Ketoacidosis
        Dr. Herold is
        Experienced
        . Learn about Diabetic Ketoacidosis.
        See more Diabetic Ketoacidosis experts
      • Hypothyroidism
        Dr. Herold is
        Experienced
        . Learn about Hypothyroidism.
        See more Hypothyroidism experts
      • Infant Hyperglycemia
        Dr. Herold is
        Experienced
        . Learn about Infant Hyperglycemia.
        See more Infant Hyperglycemia experts
      • Islet Cell Transplantation
        Dr. Herold is
        Experienced
        . Learn about Islet Cell Transplantation.
        See more Islet Cell Transplantation experts
      • Low Blood Sugar
        Dr. Herold is
        Experienced
        . Learn about Low Blood Sugar.
        See more Low Blood Sugar experts
      • Maturity Onset Diabetes of the Young
        Dr. Herold is
        Experienced
        . Learn about Maturity Onset Diabetes of the Young.
        See more Maturity Onset Diabetes of the Young experts
      View All 9 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.